Skip to main content
Premium Trial:

Request an Annual Quote

Max Planck Society to Expand into Florida

NEW YORK (GenomeWeb News) – The Max Planck Society plans to open a biomedical research institute in West Palm Beach, Fla., to be called the Max Planck Florida Institute, the Business Development Board of Palm Beach County said Wednesday.
The county has approved $86.9 million in funding to help build and run the 100,000-square-foot facility, which the BDB said it will break ground on in around 18 months. In the spring of 2009, the institute will move into its temporary facilities at Florida Atlantic University’s MacArthur campus in Jupiter.
Including funding from FAU, the total value of the agreement is $94 million, and it includes a 50-year sub-lease on land valued at around $6 million.
The Florida Governor’s Office of Tourism, Trade, and Economic Development agreed in March to unlock a total of $94 million from the state’s Innovation Incentive Fund, of which it has disbursed $10 million so far.
The Max Planck Florida Institute will collaborate with nearby Scripps Florida on health-oriented research, and it will establish relationships with Florida Atlantic University, Palm Beach Community College, and other universities in the region.


Max Planck Society President Peter Gruss said the Palm Beach area is ideal “because of our synergy with Scripps, and the proven commitment of the county and the community to enhance the life sciences sector.”
The new institute “plans to advance the world’s knowledge of bioimaging by using advanced techniques to study the molecular process,” according to the BDB’s statement.
“When we achieve a deeper understanding of the structure, dynamics and function of molecules and tissues, we can then address some of the most challenging problems in biology, bioengineering and medicine,” Gruss added.
BDB CEO Kelly Smallridge said in the statement that the research organization will directly or indirectly support the creation of over 1,800 jobs over the coming 20 years, and it will generate over $2 billion in economic activity.

The Scan

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.

Sequencing Study Leads to Vaccine Target in Bacteria Behind Neonatal Meningitis

Researchers eBioMedicine track down potential vaccine targets with transposon sequencing on mutant bacteria causing neonatal meningitis in mouse models of the disease.

Multiple Myeloma Progression Influenced by Immune Microenvironment Expression

Researchers in NPJ Genomic Medicine compare RNA sequencing profiles of 102,207 individual cells in bone marrow samples from 18 individuals with rapid or non-progressing multiple myeloma.

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.